Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010990
Filing Date
2025-05-15
Accepted
2025-05-15 16:31:24
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 551373
2 EX-31.1 ex31-1.htm EX-31.1 8763
3 EX-31.2 ex31-2.htm EX-31.2 12032
4 EX-32.1 ex32-1.htm EX-32.1 6985
5 EX-32.2 ex32-2.htm EX-32.2 7262
  Complete submission text file 0001641172-25-010990.txt   3925990

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE juns-20250331.xsd EX-101.SCH 36818
7 XBRL CALCULATION FILE juns-20250331_cal.xml EX-101.CAL 41522
8 XBRL DEFINITION FILE juns-20250331_def.xml EX-101.DEF 136835
9 XBRL LABEL FILE juns-20250331_lab.xml EX-101.LAB 344150
10 XBRL PRESENTATION FILE juns-20250331_pre.xml EX-101.PRE 256487
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 435010
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41265 | Film No.: 25954181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)